Peanut allergy patients ready for Peninsula company's new drug as COVID-19 slows launch
From social distancing for patients to company representatives meeting with allergists and payers, the rollout of the drug is anything but normal.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Allergy | Allergy & Immunology | COVID-19 | Health Management | Peanuts | Pharmaceuticals